FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Alexandra Calmy

Research Profile

Disorders

Chemicals & Drugs

Concepts & Ideas

Procedures

Living Beings

HIV-1

Geographic Areas

Switzerland

Co-author Network

Publications

TOP 3
Manel Aouri; Thierry Buclin; Alexandra Calmy; Matthias Cavassini; Bernard Hirschel; Andri Rauch; Amalio Telenti; Laurent A Decosterd
A validated assay by liquid chromatography-tandem mass spectrometry for the simultaneous quantification of elvitegravir and rilpivirine in HIV positive patients.
Maryline Bonnet; Alexandra Calmy; Laura Ciaffi; Ilesh V Jani; Christophe Michon; Elizabete Nunes; Christine Rouzioux; Carlota Silva; Agnès Sobry; Anne-Marie Taburet; Rui Bastos; Elisabeth Baudin; Nilesh Bhatt
Nevirapine versus efavirenz for patients co-infected with HIV and tuberculosis: a randomised non-inferiority trial.
Rainer Weber; Manuel Battegay; Enos Bernasconi; Alexandra Calmy; Matthias Cavassini; M Flepp; Hansjakob Furrer; J Kowalska; bruno ledergerber; Martin Rickenbach; M Ruppik; Patrick Schmid; A Spoerri
Decreasing mortality and changing patterns of causes of death in the Swiss HIV Cohort Study.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Alexandra Calmy (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Manel Aouri; Thierry Buclin; Alexandra Calmy; Matthias Cavassini; Bernard Hirschel; Andri Rauch; Amalio Telenti; Laurent A Decosterd
A validated assay by liquid chromatography-tandem mass spectrometry for the simultaneous quantification of elvitegravir and rilpivirine in HIV positive patients.
Journal of mass spectrometry : JMS 2013;48(5):616-25.
2013: Maryline Bonnet; Alexandra Calmy; Laura Ciaffi; Ilesh V Jani; Christophe Michon; Elizabete Nunes; Christine Rouzioux; Carlota Silva; Agnès Sobry; Anne-Marie Taburet; Rui Bastos; Elisabeth Baudin; Nilesh Bhatt
Nevirapine versus efavirenz for patients co-infected with HIV and tuberculosis: a randomised non-inferiority trial.
The Lancet infectious diseases 2013;13(4):303-12.
2013: Rainer Weber; Manuel Battegay; Enos Bernasconi; Alexandra Calmy; Matthias Cavassini; M Flepp; Hansjakob Furrer; J Kowalska; bruno ledergerber; Martin Rickenbach; M Ruppik; Patrick Schmid; A Spoerri
Decreasing mortality and changing patterns of causes of death in the Swiss HIV Cohort Study.
HIV medicine 2013;14(4):195-207.
2013: Lukas Fenner; Reno Frei; Hansjakob Furrer; Sebastien Gagneux; Thomas Gsponer; Peter Helbling; Matthias Hoffmann; Jean-Paul Janssens; Hans L Rieder; Jacques Schrenzel; David Stucki; Marcel Zwahlen; Marie Ballif; Manuel Battegay; Enos Bernasconi; Thomas Bodmer; Sonia Borrell; Erik C Böttger; Alexandra Calmy; Matthias Cavassini; Marisa Dolina; Matthias Egger; Jan Fehr
HIV infection disrupts the sympatric host-pathogen relationship in human tuberculosis.
PLoS genetics 2013;9(3):e1003318.
2013: Mihir Gupta; Jason Lazar; Christopher J Miller; James D Neaton; Elsayed Z Soliman; Jason V Baker; Johannes R Bogner; Alexandra Calmy
Biomarkers and electrocardiographic evidence of myocardial ischemia in patients with human immunodeficiency virus infection.
The American journal of cardiology 2013;111(5):760-4.
2013: Samira Daou; Doron Merkler; Juan Ambrosioni Czyrko; Alexandra Calmy
Intracranial hypertension following highly active antiretroviral therapy interruption in an HIV-infected woman: case report and review of the literature.
AIDS (London, England) 2013;27(4):668-70.
2013: Samanta Simioni; Jean-Marie Annoni; Alexandra Calmy; Matthias Cavassini; Aurélie Fayet-Mello; Ezio Giacobini; Bernard Hirschel; Katia Iglesias; Samantha Jilek; Mélanie Métral; Hubertus Müller; Aline Rimbault Abraham; Renaud A Du Pasquier
Rivastigmine for HIV-associated neurocognitive disorders: a randomized crossover pilot study.
Neurology 2013;80(6):553-60.
2013: D L Vu; S Daou; Juan Ambrosioni Czyrko; Alexandra Calmy
[What's new in HIV/AIDS: Some selected topics].
Revue médicale suisse 2013;9(369):150-5.
2013: Rubin Lubomirov; Raquel Martinez; Catia Marzolini; Margalida Rotger; Amalio Telenti; Mona Arab-Alameddine; Enos Bernasconi; Thierry Buclin; Alexandra Calmy; Matthias Cavassini; Chantal Csajka; Laurent A Decosterd; Julia di Iulio; Aurélie Fayet-Mello; Hansjakob Furrer; Monia Guidi; Huldrych F Günthard
Pharmacogenetics-based population pharmacokinetic analysis of etravirine in HIV-1 infected individuals.
Pharmacogenetics and genomics 2013;23(1):9-18.
2012: Kuntheavy I Lorenzini; Michela C Rebsamen; Juan Ambrosioni Czyrko; Benjamin Assouline; Alexandra Calmy; Youssef Daali; Jules Desmeules; Marc Fathi; Caroline F Samer
Serotonin syndrome following drug-drug interactions and CYP2D6 and CYP2C19 genetic polymorphisms in an HIV-infected patient.
AIDS (London, England) 2012;26(18):2417-8.
2012: Gilles Wandeler; Enos Bernasconi; Andrea Bregenzer; Alexandra Calmy; Olivier Clerc; Hansjakob Furrer; Thomas Gsponer; Huldrych F Günthard; Andri Rauch; Marcel Stöckle
Hepatitis C virus infections in the Swiss HIV Cohort Study: a rapidly evolving epidemic.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2012;55(10):1408-16.
2012: Nathan Ford; Alexandra Calmy
Efavirenz is not a known teratogen.
The Pediatric infectious disease journal 2012;31(9):999; author reply 1000.
2012: Nathan Ford; Teri Roberts; Alexandra Calmy
Viral load monitoring in resource-limited settings: a medical and public health priority.
AIDS (London, England) 2012;26(13):1719-20.
2012: M Huber; R Jaccard; bruno ledergerber; Dunja Nicca; C Orasch; R Sauter; Rainer Weber; Jim Young; Manuel Battegay; Enos Bernasconi; Alexandra Calmy; A Cusini; J Fehr; L Held
Outcome of smoking cessation counselling of HIV-positive persons by HIV care physicians.
HIV medicine 2012;13(7):387-97.
2012: Nathan Ford; Alexandra Calmy
Expert reviews: who are they for?
Expert opinion on pharmacotherapy 2012;13(8):1083-5.
2012: Lukas Fenner; Hansjakob Furrer; Sebastien Gagneux; Katia Jaton; Béatrice Ninet; Gaby E Pfyffer; Hans H Siegrist; Jesica Mazza Stalder; Marcel Zwahlen; Ekkehardt Altpeter; Thomas Bodmer; Sonia Borrell; Erik C Böttger; Thomas Bruderer; Alexandra Calmy; O Dubuis; Matthias Egger; Jan Fehr
Effect of mutation and genetic background on drug resistance in Mycobacterium tuberculosis.
Antimicrobial agents and chemotherapy 2012;56(6):3047-53.
2012: Juan Ambrosioni Czyrko; F Negro; Alexandra Calmy
[The challenges of HIV-HCV co-infection].
Revue médicale suisse 2012;8(338):905-10.
2012: Damjan S Nikolic; Nicolas Balagué; Alexandra Calmy; Alexandre Campanelli; Badwi Elias; Laurence Toutous-Trellu
[Injectable soft tissue fillers: are they medical devices or drugs? Implications for HIV lipodystrophy].
Revue médicale suisse 2012;8(335):747-53.
2012: François Dabis; Antonella d'Arminio Monforte; Stéphane De Wit; Matthias Egger; Jade Ghosn; Jesper Grarup; Virginia Isern; Ole Kirk; Catherine Leport; Charlotte Lewden; Murielle Mary-Krause; Amanda Mocroft; Cristina Mussini; Niels Obel; George Panos; Santiago Perez-Hoyos; Caroline Sabin; Paz Sobrino-Vegas; Christoph Stephan; Ramón Teira; Carlo Torti; Ard van Sighem; Jan Christian Wasmuth; Andrea Antinori; Vincent Bouteloup; Alexandra Calmy; Antonella Castagna; Geneviève Chêne
All-cause mortality in treated HIV-infected adults with CD4 ≥500/mm3 compared with the general population: evidence from a large European observational cohort collaboration.
International journal of epidemiology 2012;41(2):433-45.
2012: Alexandra Calmy; Christophe Combescure; Cecile Delhumeau; Bernard Hirschel; L Kaiser; S Meier; A Nguyen; Claire-Anne Siegrist; Sabine Yerly; M Bel
Strong serological responses and HIV RNA increase following AS03-adjuvanted pandemic immunization in HIV-infected patients.
HIV medicine 2012;13(4):207-18.
2012: Manel Aouri; Thierry Buclin; Alexandra Calmy; Laurent A Decosterd; Bernard Hirschel; Françoise Livio
Drug interactions between voriconazole, darunavir/ritonavir and etravirine in an HIV-infected patient with Aspergillus pneumonia.
AIDS (London, England) 2012;26(6):776-8.
2012: Jim Young; Manuel Battegay; Enos Bernasconi; Heiner C Bucher; Alexandra Calmy; Matthias Cavassini; Hansjakob Furrer; Christoph A Fux; Juliane Schäfer; Pietro Vernazza; Rainer Weber
Renal function in patients with HIV starting therapy with tenofovir and either efavirenz, lopinavir or atazanavir.
AIDS (London, England) 2012;26(5):567-75.
2012: Lukas Fenner; Hansjakob Furrer; Sebastien Gagneux; Peter Helbling; Jean-Paul Janssens; Katia Jaton; Beatrice Ninet; Gaby E Pfyffer; Hans L Rieder; Hans H Siegrist; Jesica Mazza Stalder; David Stucki; Marcel Zwahlen; Manuel Battegay; Thomas Bodmer; Erik C Böttger; Alexandra Calmy; Marisa Dolina; Matthias Egger; Jan Fehr
Mycobacterium tuberculosis transmission in a country with low tuberculosis incidence: role of immigration and HIV infection.
Journal of clinical microbiology 2012;50(2):388-95.
2012: C Thierfelder; Rainer Weber; Enos Bernasconi; Alexandra Calmy; Matthias Cavassini; Luigia Elzi; Hansjakob Furrer; C Gutmann; bruno ledergerber
Participation, characteristics and retention rates of HIV-positive immigrants in the Swiss HIV Cohort Study.
HIV medicine 2012;13(2):118-26.
2012: Olivia Keiser; bruno ledergerber; Dunja Nicca; Andri Rauch; Ben Spycher; Alexandra Calmy; Matthias Cavassini; Matthias Egger; Tracy R Glass
Outcomes of antiretroviral therapy in the Swiss HIV Cohort Study: latent class analysis.
AIDS and behavior 2012;16(2):245-55.
2012: Alexandra U Scherrer; Pietro L Vernazza; Sabine Yerly; Vincent Aubert; Enos Bernasconi; Jürg Böni; Alexandra Calmy; Matthias Cavassini; Luigia Elzi; Hansjakob Furrer; Huldrych F Günthard; Thomas Klimkait; bruno ledergerber
Long-lasting protection of activity of nucleoside reverse transcriptase inhibitors and protease inhibitors (PIs) by boosted PI containing regimens.
PloS one 2012;7(11):e50307.
2012: Isabelle Andrieux-Meyer; Pedro Cahn; Alexandra Calmy; Polly Clayden; Nathan Ford; Eric Goemaere; Christine Katlama; Andrew Levin; Sharonann Lynch; Gilles Raguin; Marco Vitoria
Preferred antiretroviral drugs for the next decade of scale up.
Journal of the International AIDS Society 2012;15(2):17986.
2012: Claire-Anne Siegrist; Paola M Soccal; Christian van Delden; Sabine Yerly; Michael Bel; Alexandra Calmy; Matthias Cavassini; Olivier Clerc; Christophe Combescure; Cécile Delhumeau; Karine Hadaya; Bernard Hirschel; Laurent Kaiser; Sara Meier
Higher memory responses in HIV-infected and kidney transplanted patients than in healthy subjects following priming with the pandemic vaccine.
PloS one 2012;7(7):e40428.
2012: Alexandra Calmy; François Dabis; Eric Delaporte; Matthias Egger; Kamal Marhoum El Filali; N Kumarasamy; James McIntyre; Patrick McPhail; Eugène Messou; Mauro Schechter; Eduardo Sprinz; Rodolphe Thiébaut; Stefaan Van der Borght; Robin Wood; Carlos Zala; Eric Balestre; david bangsberg; Fabrice Bonnet; Andrew Boulle
Mean CD4 cell count changes in patients failing a first-line antiretroviral therapy in resource-limited settings.
BMC infectious diseases 2012;12():147.
2012: Alexandra U Scherrer; Pietro L Vernazza; Viktor von Wyl; Sabine Yerly; Enos Bernasconi; Jürg Böni; Alexandra Calmy; Matthias Cavassini; Cristina Cellerai; Luigia Elzi; Hansjakob Furrer; Huldrych Günthard; Thomas Klimkait; bruno ledergerber
Minor protease inhibitor mutations at baseline do not increase the risk for a virological failure in HIV-1 subtype B infected patients.
PloS one 2012;7(6):e37983.
2012: Janice Soo Fern Lee; Isabelle Andrieux-Meyer; Alexandra Calmy; Nathan Ford
Review of the safety, efficacy, and pharmacokinetics of elvitegravir with an emphasis on resource-limited settings.
HIV/AIDS (Auckland, N.Z.) 2012;4():5-15.
2012: Cornelia Staehelin; Rainer Weber; Enos Bernasconi; Alexandra Calmy; Matthias Cavassini; Luigia Elzi; Hansjakob Furrer; Olivia Keiser; Patrick Schmid
Longer term clinical and virological outcome of sub-Saharan African participants on antiretroviral treatment in the Swiss HIV Cohort Study.
Journal of acquired immune deficiency syndromes (1999) 2012;59(1):79-85.
2011: Nathan Ford; Alexandra Calmy; Lynne Mofenson
Safety of efavirenz in the first trimester of pregnancy: an updated systematic review and meta-analysis.
AIDS (London, England) 2011;25(18):2301-4.
2011: Florian Charbonnier; Alexandra Calmy; Jean-Paul Janssens
[Tuberculosis and HIV co-infection: a therapeutic challenge].
Revue médicale suisse 2011;7(318):2295-6, 2298-300.
2011: Catia Marzolini; Pietro Vernazza; Rainer Weber; David Back; Manuel Battegay; Enos Bernasconi; Alexandra Calmy; Matthias Cavassini; Luigia Elzi; Hansjakob Furrer; Saye Khoo
Ageing with HIV: medication use and risk for potential drug-drug interactions.
The Journal of antimicrobial chemotherapy 2011;66(9):2107-11.
2011: E Boffi El Amari; Hansjakob Furrer; Barbara Hasse; Hh Hirsch; Bernard Hirschel; L Kaiser; Pietro Vernazza; Sabine Yerly; Enos Bernasconi; Alexandra Calmy; Matthias Cavassini; Christophe Combescure
Clinical relevance of cytomegalovirus viraemia(*,†).
HIV medicine 2011;12(7):394-402.
2011: Alain Nguyen; Andri Rauch; Patrick Schmid; Aurelie F Mello; Isabelle Mercier; Enos Bernasconi; Alexandra Calmy; Matthias Cavassini; Cecile Delhumeau; Luigia Elzi; Bernard Hirschel
A randomized cross-over study to compare raltegravir and efavirenz (SWITCH-ER study).
AIDS (London, England) 2011;25(12):1481-7.
2011: Pascal Gervaz; Abdelkarim S Allal; Alexandra Calmy; Ymer Durmishi; Philippe Morel
Squamous cell carcinoma of the anus-an opportunistic cancer in HIV-positive male homosexuals.
World journal of gastroenterology : WJG 2011;17(25):2987-91.
2011: Antoine Benard; Françoise Brun Vezinet; Alexandra Calmy; Geneviève Chene; Florence Damond; Sophie Matheron; Jean Ruelle; Vicente Soriano; Audrey Taieb; Emilia Valadas; Ard van Sighem; Claudia Balotta
Immunovirological response to triple nucleotide reverse-transcriptase inhibitors and ritonavir-boosted protease inhibitors in treatment-naive HIV-2-infected patients: The ACHIEV2E Collaboration Study Group.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2011;52(10):1257-66.
2011: Alexandra Calmy; Véronique Schiffer; Bernard Hirschel
[HIV and AIDS: what's new in 2010?].
Revue médicale suisse 2011;7(278):159-63.
2011: Alain Nguyen; Alexandra Calmy; Cécile Delhumeau; Isabelle K Mercier; Matthias Cavassini; Aurélie Fayet-Mello; Luigia Elzi; Daniel Genné; Andri Rauch; Enos Bernasconi; Bernard Hirschel
A randomized crossover study to compare efavirenz and etravirine treatment.
AIDS (London, England) 2011;25(1):57-63.
2011: Nathan Ford; Janice Lee; Isabelle Andrieux-Meyer; Alexandra Calmy
Safety, efficacy, and pharmacokinetics of rilpivirine: systematic review with an emphasis on resource-limited settings.
HIV/AIDS (Auckland, N.Z.) 2011;3():35-44.
2011: Nathan Ford; Alexandra Calmy; Edward J Mills
The first decade of antiretroviral therapy in Africa.
Globalization and health 2011;7():33.
2011: Juan Ambrosioni Czyrko; Alexandra Calmy; Bernard Hirschel
HIV treatment for prevention.
Journal of the International AIDS Society 2011;14():28.
2011: Aurélie Fayet Mello; Thierry Buclin; Laurent A Decosterd; Cécile Delhumeau; Julia di Iulio; Alessandra Fleurent; Marie-Paule Schneider; Matthias Cavassini; Amalio Telenti; Bernard Hirschel; Alexandra Calmy
Successful efavirenz dose reduction guided by therapeutic drug monitoring.
Antiviral therapy 2011;16(2):189-97.
2011: Ellen 't Hoen; Jonathan Berger; Alexandra Calmy; Suerie Moon
Driving a decade of change: HIV/AIDS, patents and access to medicines for all.
Journal of the International AIDS Society 2011;14():15.
2010: Michael Neely; Laurent Decosterd; Aurélie Fayet; Janice Soo Fern Lee; Ashley Margol; Meera Kanani; Julia di Iulio; Tido von Schoen-Angerer; Roger Jelliffe; Alexandra Calmy
Pharmacokinetics and pharmacogenomics of once-daily raltegravir and atazanavir in healthy volunteers.
Antimicrobial agents and chemotherapy 2010;54(11):4619-25.
2010: Alexandra Calmy; M Bloch; H Wand; C Delhumeau; R Finlayson; M Rafferty; R Norris; Bernard Hirschel; David A Cooper; Andrew Carr
No significant effect of uridine or pravastatin treatment for HIV lipoatrophy in men who have ceased thymidine analogue nucleoside reverse transcriptase inhibitor therapy: a randomized trial.
HIV medicine 2010;11(8):493-501.
2010: Melissa I Dominicé Dao; Jackeline F Ferreira; Nathalie Vallier; Dominique Roulin; Bernard Hirschel; Alexandra Calmy
Health perceptions of African HIV-infected patients and their physicians.
Patient education and counseling 2010;80(2):185-90.
2010: Mar Pujades-Rodríguez; Suna Balkan; Line Arnould; Martin A W Brinkhof; Alexandra Calmy
Treatment failure and mortality factors in patients receiving second-line HIV therapy in resource-limited countries.
JAMA : the journal of the American Medical Association 2010;304(3):303-12.
2010: Angela Huttner; Alexandra Calmy
Treatment of HIV infection with drugs for HSV-2 infection.
Lancet 2010;376(9735):88; author reply 88.
2010: Nathan Ford; Lynne Mofenson; Katharina Kranzer; Lanre Medu; Lisa Frigati; Edward J Mills; Alexandra Calmy
Safety of efavirenz in first-trimester of pregnancy: a systematic review and meta-analysis of outcomes from observational cohorts.
AIDS (London, England) 2010;24(10):1461-70.
2010: Jacqueline Neuhaus; David R Jacobs; Jason V Baker; Alexandra Calmy; Daniel Duprez; Alberto La Rosa; Lewis H Kuller; Sarah L Pett; Matti Ristola; Michael J Ross; Michael G Shlipak; Russell Tracy; James D Neaton
Markers of inflammation, coagulation, and renal function are elevated in adults with HIV infection.
The Journal of infectious diseases 2010;201(12):1788-95.
2010: Samanta Simioni; Matthias Cavassini; Jean-Marie Annoni; Aline Rimbault Abraham; Isabelle Bourquin; Véronique Schiffer; Alexandra Calmy; Jean-Philippe Chave; Ezio Giacobini; Bernard Hirschel; Renaud A Du Pasquier
Cognitive dysfunction in HIV patients despite long-standing suppression of viremia.
AIDS (London, England) 2010;24(9):1243-50.
2010: Nicolas Mueller; Christoph A Fux; bruno ledergerber; Luigia Elzi; Patrick Schmid; Thanh Dang; Lorenzo Magenta; Alexandra Calmy; Athanasios Vergopoulos; Heike A Bischoff-Ferrari
High prevalence of severe vitamin D deficiency in combined antiretroviral therapy-naive and successfully treated Swiss HIV patients.
AIDS (London, England) 2010;24(8):1127-34.
2010: Martine Usdin; Martine Guillerm; Alexandra Calmy
Patient needs and point-of-care requirements for HIV load testing in resource-limited settings.
The Journal of infectious diseases 2010;201 Suppl 1():S73-7.
2010: Rubin Lubomirov; Julia di Iulio; Aurélie Fayet; Sara Colombo; Raquel Martinez; Catia Marzolini; Hansjakob Furrer; Pietro Vernazza; Alexandra Calmy; Matthias Cavassini; bruno ledergerber; Katharina Rentsch; Patrick Descombes; Thierry Buclin; Laurent A Decosterd; Chantal Csajka; Amalio Telenti
ADME pharmacogenetics: investigation of the pharmacokinetics of the antiretroviral agent lopinavir coformulated with ritonavir.
Pharmacogenetics and genomics 2010;20(4):217-30.
2010: Noelle Junod Perron; Melissa Dominicé Dao; Michel P Kossovsky; Valerie Miserez; Carmen Chuard; Alexandra Calmy; Jean-Michel Gaspoz
Reduction of missed appointments at an urban primary care clinic: a randomised controlled study.
BMC family practice 2010;11():79.
2010: Catia Marzolini; Luigia Elzi; Sara Gibbons; Rainer Weber; Christoph Fux; Hansjakob Furrer; Jean-Philippe Chave; Matthias Cavassini; Enos Bernasconi; Alexandra Calmy; Pietro Vernazza; Saye Khoo; bruno ledergerber; David Back; Manuel Battegay
Prevalence of comedications and effect of potential drug-drug interactions in the Swiss HIV Cohort Study.
Antiviral therapy 2010;15(3):413-23.
2010: Nathan Ford; Alexandra Calmy; Samia Hurst
When to start antiretroviral therapy in resource-limited settings: a human rights analysis.
BMC international health and human rights 2010;10():6.
2010: Jules B Tchatchueng Mbougua; Christian Laurent; Charles Kouanfack; Anke Bourgeois; Laura Ciaffi; Alexandra Calmy; Henri Gwet; Sinata Koulla-Shiro; Jacques Ducos; Eitel Mpoudi-Ngolé; Nicolas Molinari; Eric Delaporte
Hepatotoxicity and effectiveness of a Nevirapine-based antiretroviral therapy in HIV-infected patients with or without viral hepatitis B or C infection in Cameroon.
BMC public health 2010;10():105.
2010: Nathan Ford; Alexandra Calmy
Improving first-line antiretroviral therapy in resource-limited settings.
Current opinion in HIV and AIDS 2010;5(1):38-47.
2010: Tristan Ferry; Bernard Hirschel; Thanh Dang; Pascal Meylan; Cécile Delhumeau; Andri Rauch; Rainer Weber; Luigia Elzi; Enos Bernasconi; Patrick Schmid; Alexandra Calmy
Infrequent replication of parvovirus B19 and erythrovirus genotypes 2 and 3 among HIV-infected patients with chronic anemia.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2010;50(1):115-8.
2010: Christian Laurent; Anke Bourgeois; Eitel Mpoudi-Ngolé; Charles Kouanfack; L Ciaffi; N Nkoué; Rose Mougnutou; Alexandra Calmy; Sinata Koulla-Shiro; J Ducos; Eric Delaporte
High rates of active hepatitis B and C co-infections in HIV-1 infected Cameroonian adults initiating antiretroviral therapy.
HIV medicine 2010;11(1):85-9.
2009: Alexandra Calmy; Christoph A Fux; Richard Norris; Nathalie Vallier; Cécile Delhumeau; Katherine Samaras; Karl Hesse; Bernard Hirschel; David A Cooper; Andrew Carr
Low bone mineral density, renal dysfunction, and fracture risk in HIV infection: a cross-sectional study.
The Journal of infectious diseases 2009;200(11):1746-54.
2009: Asgeir Johannessen; Marius Trøseid; Alexandra Calmy
Dried blood spots can expand access to virological monitoring of HIV treatment in resource-limited settings.
The Journal of antimicrobial chemotherapy 2009;64(6):1126-9.
2009: Helen Kovari; bruno ledergerber; Ulrich Peter; Markus Flepp; Josef Jost; Patrick Schmid; Alexandra Calmy; Nicolas J Mueller; Beat Muellhaupt; Rainer Weber
Association of noncirrhotic portal hypertension in HIV-infected persons and antiretroviral therapy with didanosine: a nested case-control study.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2009;49(4):626-35.
2009: Alexandra Calmy; Angèle Gayet-Ageron; Fabrizio Montecucco; Alain Nguyen; François Mach; Fabienne Burger; Sasiwimol Ubolyam; Andrew Carr; Kiat Ruxungtham; Bernard Hirschel; Jintanat Ananworanich
HIV increases markers of cardiovascular risk: results from a randomized, treatment interruption trial.
AIDS (London, England) 2009;23(8):929-39.
2009: Nathan Ford; Edward Mills; Alexandra Calmy
Rationing antiretroviral therapy in Africa--treating too few, too late.
The New England journal of medicine 2009;360(18):1808-10.
2009: Alexandra Calmy; Nathalie Vallier; Alain Nguyen; Joep Ma Lange; Manuel Battegay; Frank de Wolf; Peter Reiss; Viviane D Lima; Bernard Hirschel; Hogg Robert; Benita Yip; Julio S G Montaner; Ferdinand W Wit
Safety and efficacy of once-daily nevirapine dosing: a multicohort study.
Antiviral therapy 2009;14(7):931-8.
2009: Alessandro Soria; Klaudia Porten; Jean-Calvin Fampou-Toundji; Laura Galli; Rose Mougnutou; Vincent Buard; Anfumbom Kfutwah; Aurelia Vessière; Dominique Rousset; Roger Teck; Alexandra Calmy; Laura Ciaffi; Adriano Lazzarin; Nicola Gianotti
Resistance profiles after different periods of exposure to a first-line antiretroviral regimen in a Cameroonian cohort of HIV type-1-infected patients.
Antiviral therapy 2009;14(3):339-47.
2009: Alexandra Calmy; Bernard Hirschel; David A Cooper; Andrew Carr
A new era of antiretroviral drug toxicity.
Antiviral therapy 2009;14(2):165-79.
2008: Alexandra Calmy; Cecilia Pizzocolo; Louis Pizarro; Gilles Brücker; Robert Murphy; Christine Katlama
The marriage of science and optimized HIV care in resource-limited settings.
AIDS (London, England) 2008;22(17):2227-30.
2008: Julian H Elliott; Lutgarde Lynen; Alexandra Calmy; Andrea De Luca; Robert W Shafer; Maria Zolfo; Bonaventura Clotet; Sarah Huffam; Charles A B Boucher; David A Cooper; Jonathan M Schapiro
Rational use of antiretroviral therapy in low-income and middle-income countries: optimizing regimen sequencing and switching.
AIDS (London, England) 2008;22(16):2053-67.
2008: Stephen D Lawn; Linda-Gail Bekker; Alexandra Calmy; Robin Wood
Monitoring of antiretroviral therapy in low-resource settings.
Lancet 2008;372(9635):287-8; author reply 289.
2008: Mar Pujades-Rodríguez; Daniel O'Brien; Pierre Humblet; Alexandra Calmy
Second-line antiretroviral therapy in resource-limited settings: the experience of Médecins Sans Frontières.
AIDS (London, England) 2008;22(11):1305-12.
2008: Jens van Roey; Tido von Schoen-Angerer; Nathan Ford; Alexandra Calmy
How developing world concerns need to be part of drug development plans: a case study of four emerging antiretrovirals.
Drug discovery today 2008;13(13-14):601-5.
2008: Charles Kouanfack; Christian Laurent; Gilles Peytavin; Laura Ciaffi; Maguy Ngolle; Yvette Mawamba Nkene; Claudine Essomba; Alexandra Calmy; Eitel Mpoudi-Ngolé; Eric Delaporte; Sinata Koulla-Shiro
Adherence to antiretroviral therapy assessed by drug level monitoring and self-report in cameroon.
Journal of acquired immune deficiency syndromes (1999) 2008;48(2):216-9.
2008: Bernard Hirschel; Alexandra Calmy
Initial treatment for HIV infection--an embarrassment of riches.
The New England journal of medicine 2008;358(20):2170-2.
2008: Christian Laurent; Anke Bourgeois; Eitel Mpoudi-Ngolé; Laura Ciaffi; Charles Kouanfack; Rose Mougnutou; Nathalie Nkoué; Alexandra Calmy; Sinata Koulla-Shiro; Eric Delaporte
Tolerability and effectiveness of first-line regimens combining nevirapine and lamivudine plus zidovudine or stavudine in Cameroon.
AIDS research and human retroviruses 2008;24(3):393-9.
2007: Handan Wand; Alexandra Calmy; Dianne L Carey; Katherine Samaras; Andrew Carr; Matthew G Law; David A Cooper; Sean Emery
Metabolic syndrome, cardiovascular disease and type 2 diabetes mellitus after initiation of antiretroviral therapy in HIV infection.
AIDS (London, England) 2007;21(18):2445-53.
2007: S E Huffam; Preeyaporn Srasuebkul; Jialun Zhou; Alexandra Calmy; Vonthanak Saphonn; John M Kaldor; Rossana Ditangco
Prior antiretroviral therapy experience protects against zidovudine-related anaemia.
HIV medicine 2007;8(7):465-71.
2007: Alexandra Calmy; Bernard Hirschel; David A Cooper; Andrew Carr
Clinical update: adverse effects of antiretroviral therapy.
Lancet 2007;370(9581):12-4.
2007: Christian Laurent; Charles Kouanfack; Sinata Koulla-Shiro; Maguy Njoume; Yvette Mawamba Nkene; Laura Ciaffi; Charlotte Brulet; Gilles Peytavin; Laurence Vergne; Alexandra Calmy; Eitel Mpoudi-Ngolé; Eric Delaporte
Long-term safety, effectiveness and quality of a generic fixed-dose combination of nevirapine, stavudine and lamivudine.
AIDS (London, England) 2007;21(6):768-71.
2007: Preeyaporn Srasuebkul; Alexandra Calmy; Jialun Zhou; Nagalingeswaran Kumarasamy; Matthew Law; Poh Lian Lim
Impact of drug classes and treatment availability on the rate of antiretroviral treatment change in the TREAT Asia HIV Observational Database (TAHOD).
AIDS research and therapy 2007;4():18.
2007: Nathan Ford; Alexandra Calmy; Tido von Schoen-Angerer
Treating HIV in the developing world: getting ahead of the drug development curve.
Drug discovery today 2007;12(1-2):1-3.
2007: Alexandra Calmy; Nathan Ford; Bernard Hirschel; Steven J Reynolds; Lutgarde Lynen; Eric Goemaere; Felipe Garcia de la Vega; Luc Perrin; William Rodriguez
HIV viral load monitoring in resource-limited regions: optional or necessary?
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2007;44(1):128-34.
2006: Alexandra Calmy; Fernando Pascual; Sheila Shettle; Felipe Garcia de la Vega; Nathan Ford
(The Lancet)red: a missed opportunity.
Lancet 2006;368(9541):1063.
2006: Alexandra Calmy; Loretxu Pinoges; Elisabeth Szumilin; Rony Zachariah; Nathan Ford; Laurent Ferradini
Generic fixed-dose combination antiretroviral treatment in resource-poor settings: multicentric observational cohort.
AIDS (London, England) 2006;20(8):1163-9.
2005: Anke Bourgeois; Christian Laurent; Rose Mougnutou; Nathalie Nkoué; Bernadette Lactuock; Laura Ciaffi; Florian Liegeois; Isabelle Andrieux-Meyer; Leopold Zekeng; Alexandra Calmy; Eitel Mpoudi-Ngolé; Eric Delaporte
Field assessment of generic antiretroviral drugs: a prospective cohort study in Cameroon.
Antiviral therapy 2005;10(2):335-41.
2004: Alexandra Calmy; Elise Klement; Roger Teck; Daniel Berman; Bernard Pécoul; Laurent Ferradini
Simplifying and adapting antiretroviral treatment in resource-poor settings: a necessary step to scaling-up.
AIDS (London, England) 2004;18(18):2353-60.
2004: Milos Opravil; Doris Baumann; Jean-Philippe Chave; Hansjakob Furrer; Alexandra Calmy; Enos Bernasconi; Monika Blasko; Pietro Vernazza; bruno ledergerber; Luc Perrin
Long-term efficacy after switch from protease inhibitor-containing highly active antiretroviral therapy to abacavir, lamivudine, and zidovudine.
AIDS (London, England) 2004;18(16):2213-5.
2004: Alexandra Calmy; Fernando Pascual; Nathan Ford
First-line and second-line antiretroviral therapy.
Lancet 2004;364(9431):329; author reply 330.
2004: Christian Laurent; Charles Kouanfack; Sinata Koulla-Shiro; Nathalie Nkoué; Anke Bourgeois; Alexandra Calmy; Bernadette Lactuock; Viviane Nzeusseu; Rose Mougnutou; Gilles Peytavin; Florian Liegeois; Eric Nerrienet; Michèle Tardy; Martine Peeters; Isabelle Andrieux-Meyer; Leopold Zekeng; Michel D Kazatchkine; Eitel Mpoudi-Ngolé; Eric Delaporte
Effectiveness and safety of a generic fixed-dose combination of nevirapine, stavudine, and lamivudine in HIV-1-infected adults in Cameroon: open-label multicentre trial.
Lancet 2004;364(9428):29-34.
2004: Alexandra Calmy; Fernando Pascual; Nathan Ford
HIV drug resistance.
The New England journal of medicine 2004;350(26):2720-1.
2004: Jean-Philippe Zuber; Alexandra Calmy; John M Evison; Barbara Hasse; Veronique Schiffer; Thomas Wagels; Reto Nüesch; Lorenzo Magenta; bruno ledergerber; Rolf Jenni; Rudolf Speich; Milos Opravil
Pulmonary arterial hypertension related to HIV infection: improved hemodynamics and survival associated with antiretroviral therapy.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2004;38(8):1178-85.
2003: Jean-Michel Tassie; Elisabeth Szumilin; Alexandra Calmy; Eric Goemaere
Highly active antiretroviral therapy in resource-poor settings: the experience of Médecins Sans Frontières.
AIDS (London, England) 2003;17(13):1995-7.
2003: Alexandra Calmy; Bernard Hirschel; Didier Hans; Véronique L Karsegard; Christoph A Meier
Glitazones in lipodystrophy syndrome induced by highly active antiretroviral therapy.
AIDS (London, England) 2003;17(5):770-2.